Page 3 of 12 pages : « First  <  1 2 3 4 5 >  Last »

1. Advances in LLM: Ofatumumab: A New Agent for Chronic Lymphocytic Leukemia

H&O January 2010 Volume 8, Issue 1

Anders Österborg, MD, PhD

Download PDF

2. Advances in LLM: Imatinib: High Dose Versus Standard Dose

H&O December 2009 Volume 7, Issue 12

Elias Jabbour, MD

Download PDF

3. Advances in LLM: Update on Burkitt Lymphoma and Leukemia

H&O November 2009 Volume 7, Issue 11

Dieter Hoelzer, MD, PhD

Download PDF

4. Clinical Case Review: What Causes Neurotoxicity After Exposure to Purine Analogs?

H&O November 2009 Volume 7, Issue 11

Matt Kalaycio, MD, and Clemens M. Wendtner, MD

Download PDF

5. Clinical Case Study: Bendamustine Induced Neurotoxicity

H&O November 2009 Volume 7, Issue 11

Bruce D. Cheson, MD, and Michael L. Kroll, MD

Download PDF

6. Advances in LLM: Frontline Therapy for Chronic Lymphocytic Leukemia Patients

H&O October 2009 Volume 7, Issue 10

Barbara Eichhorst, MD

Download PDF

7. Advances in LLM: Current Status of Acute Myeloid Leukemia Treatment in the Elderly

H&O September 2009 Volume 7, Issue 9

Gary Schiller, MD

Download PDF

8. Advances in LLM: Cord Blood Transplants

H&O August 2009 Volume 7, Issue 8

Marcos De Lima, MD

Download PDF

9. Advances in LLM: Molecular Markers in Acute Myeloid Leukemia

H&O July 2009 Volume 7, Issue 7

Guido Marcucci, MD

Download PDF

10. Advances in LLM: T-cell Lymphomas

H&O June 2009 Volume 7, Issue 6

Steven M. Horwitz, MD

Download PDF

Page 3 of 12 pages : « First  <  1 2 3 4 5 >  Last »